Fructose, but not dextrose, accelerates the progression of chronic kidney disease

2007 ◽  
Vol 293 (4) ◽  
pp. F1256-F1261 ◽  
Author(s):  
Michael S. Gersch ◽  
Wei Mu ◽  
Pietro Cirillo ◽  
Sirirat Reungjui ◽  
Li Zhang ◽  
...  

The metabolic syndrome has recently been recognized as a risk factor for kidney disease, but the mechanisms mediating this risk remain unclear. High fructose consumption by animals produces a model of the metabolic syndrome with hypertension, hyperlipidemia, and insulin resistance. The present study was conducted to test the hypothesis that consumption of a high-fructose diet could accelerate the progression of chronic kidney disease. Three groups of 14 male Sprague-Dawley rats were pair fed a specialized diet containing 60% fructose (FRU) or 60% dextrose (DEX) or standard rat chow (CON). After the animals were fed their assigned diet for 6 wk, five-sixths nephrectomy was performed, and the assigned diet was continued for 11 wk. Proteinuria was significantly increased and creatinine clearance was decreased in the FRU group compared with the CON and DEX groups, and blood urea nitrogen was higher in the FRU group than in the CON and DEX groups. Kidneys from the FRU group were markedly larger than kidneys from the CON and DEX groups. Glomerular sclerosis, tubular atrophy, tubular dilatation, and cellular infiltration appeared markedly worse in kidneys from the FRU group than in kidneys from the DEX and CON groups. Monocyte chemoattractant protein-1 (MCP-1) was measured in renal tissue homogenate and found to be increased in the FRU group. In vitro studies were conducted to determine the mechanism for increased renal MCP-1, and fructose stimulation of proximal tubular cells resulted in production of MCP-1. In conclusion, consumption of a high-fructose diet greatly accelerates progression of chronic kidney disease in the rat remnant kidney model.

2006 ◽  
Vol 15 (4) ◽  
pp. 361-365 ◽  
Author(s):  
Carmen A Peralta ◽  
Manjula Kurella ◽  
Joan C Lo ◽  
Glenn M Chertow

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Heather A. LaGuardia ◽  
L. Lee Hamm ◽  
Jing Chen

Metabolic syndrome is characterized by a clustering of cardiovascular risk factors, including abdominal obesity, elevated blood pressure and glucose concentrations, and dyslipidemia. The presence of this clinical entity is becoming more pervasive throughout the globe as the prevalence of obesity increases worldwide. Moreover, there is increased recognition of the complications and mortality related to this syndrome. This paper looks to examine the link between metabolic syndrome and the development of chronic kidney disease.


2007 ◽  
Vol 71 (7) ◽  
pp. 693-700 ◽  
Author(s):  
C. Kitiyakara ◽  
S. Yamwong ◽  
S. Cheepudomwit ◽  
S. Domrongkitchaiporn ◽  
N. Unkurapinun ◽  
...  

2006 ◽  
Vol 21 (12) ◽  
pp. 3608-3609 ◽  
Author(s):  
M. Kanauchi ◽  
K. Kanauchi ◽  
K. Kimura ◽  
T. Inoue ◽  
Y. Saito

2012 ◽  
Vol 188 (6) ◽  
pp. 2269-2273 ◽  
Author(s):  
Mei-Yi Wu ◽  
Yi-Lien Wu ◽  
Yung-Ho Hsu ◽  
Yuh-Feng Lin ◽  
Yang-Chih Fan ◽  
...  

2007 ◽  
Vol 35 (02) ◽  
pp. 265-277 ◽  
Author(s):  
Dae Gill Kang ◽  
Eun Jin Sohn ◽  
An Sook Lee ◽  
Jin Sook Kim ◽  
Dae Ho Lee ◽  
...  

Feeding high fructose (Frc) to rats induces a moderate increase in blood pressure, which is associated with insulin resistance. The present study was designed to evaluate the effect of the methanol extract of Sorbus commixta cortex (MSC) on vascular inflammation in a rat model of the metabolic syndrome induced by a high Frc-diet. Male Sprague-Dawley rats were divided into 4 groups and treated for 7 weeks as follows: 1) control, 2) high Frc-diet group, 3) Frc/MSC1 group; high Frc-diet group treated with MSC (100 mg/kg/day), and 4) Frc/MSC2 group; high Frc-diet group treated with MSC (200 mg/kg/day). High Frc-induced decreases of the expression level of aortic endothelial nitric oxide synthase (ecNOS) while the production of cyclic GMP (cGMP) was restored by treatment with MSC. On the contrary, increases of the expression level of endothelin-1 (ET-1) in the aorta, the transcription factor, the cytokine related with vascular inflammation, and the adhesion molecules were suppressed by MSC treatment. Moreover, MSC treatment was shown to lessen the thickening noted in the aortic intima and media of the high Frc-diet group. Our findings suggest that MSC may have an anti-vascular inflammatory effect on rats with a high Frc-induced metabolic syndrome.


Sign in / Sign up

Export Citation Format

Share Document